organophosphonates has been researched along with Acute Confusional Senile Dementia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Aliakbarzadeh, F; Hashemi, R; Khodagholi, F; Motamedi, F; Naderi, N; Naderi, S; Pourbadie, HG; Sayehmiri, F | 1 |
| Cui, W; Feng, Q; Jiang, B; Liang, H; Liang, W; Wang, B; Wang, Q; Xia, C; Xie, Y; Yan, Y; Zhao, L; Zhou, C | 1 |
| Dhavan, P; Jadhav, BL; Pavale, G; Ramana, MMV; Shaikh, S | 1 |
| Abás, S; Bagán, A; Brea, J; Brocos-Mosquera, I; Callado, LF; Daelemans, D; de Jonghe, S; Djikic, T; Escolano, C; García-Fuster, MJ; García-Sevilla, JA; Griñán-Ferré, C; Hernández-Hernández, E; Loza, MI; Luque, FJ; Molins, E; Muguruza, C; Naesens, L; Nikolic, K; Pallàs, M; Pérez, B; Pérez-Lozano, P; Radan, M; Rodríguez-Arévalo, S; Vasilopoulou, F | 1 |
| Brandon, NJ; Ellman, JA; Geschwindner, S; Käck, H; Lombroso, PJ; Nairn, AC; Read, JA; Snow, M; Wissler, L; Witten, MR | 1 |
| Dodds, S; Lange, MM; Rogers, W | 1 |
| Berghuis, AM; De Schutter, JW; Gormley, P; Hu, Z; Leung, CY; Lin, YS; Park, J; Poirier, J; Tsantrizos, YS | 1 |
| Banerjee, K; Chen, HL; Cho, S; Chu, CT; Denton, TT; Frank, DE; Gibson, GE; Jiang, JF; Kagan, VE; Munshi, S; Tyurina, YY; Xu, H; Yang, J | 1 |
| da Silva, ER; de A Novaes, B; De-Paula, VJ; Forlenza, OV; Gattaz, WF; Schaeffer, EL; Skaf, HD | 1 |
| da Silva, ER; Gattaz, WF; Joaquim, HD; Martins, BA; Novaes, Bde A; Schaeffer, EL; Skaf, HD | 1 |
| Chaney, MO; Hu, G; Valasani, KR; Yan, SS | 1 |
11 other study(ies) available for organophosphonates and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Phosphonate analog of 2-oxoglutarate regulates glutamate-glutamine homeostasis and counteracts amyloid beta induced learning and memory deficits in rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Glutamate Dehydrogenase; Glutamate-Ammonia Ligase; Glutamates; Glutamine; Hippocampus; Homeostasis; Ketoglutarate Dehydrogenase Complex; Ketoglutaric Acids; Male; Maze Learning; Memory Disorders; Organophosphonates; Peptide Fragments; Rats; Rats, Wistar | 2022 |
Superhydrophilic nanocomposite adsorbents modified
Topics: Alzheimer Disease; Animals; Caseins; Graphite; Hippocampus; Humans; Indicators and Reagents; Ionic Liquids; Ions; Mice; Mice, Transgenic; Nanocomposites; Nitrogen; Organophosphonates; Phosphopeptides; Phosphoproteins; Phosphorylation; Polyethyleneimine; Serum Albumin, Bovine; tau Proteins; Titanium | 2022 |
Design, synthesis and evaluation of pyrazole bearing α-aminophosphonate derivatives as potential acetylcholinesterase inhibitors against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amination; Animals; Cholinesterase Inhibitors; Drug Design; Electrophorus; HEK293 Cells; Humans; Molecular Docking Simulation; Organophosphonates; Pyrazoles | 2020 |
Bicyclic α-Iminophosphonates as High Affinity Imidazoline I
Topics: Alzheimer Disease; Animals; Chlorocebus aethiops; Cycloaddition Reaction; Dogs; Female; HeLa Cells; Hippocampus; Humans; Imidazoles; Imidazoline Receptors; Ligands; Madin Darby Canine Kidney Cells; Mice; Molecular Structure; Nootropic Agents; Organophosphonates; Quantitative Structure-Activity Relationship; Vero Cells | 2020 |
X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase Inhibitors.
Topics: Alzheimer Disease; Animals; Catalytic Domain; Crystallography, X-Ray; Drug Discovery; Drug Stability; Dual-Specificity Phosphatases; Microsomes, Liver; Organophosphonates; Protein Tyrosine Phosphatases, Non-Receptor; Rats; Sulfonamides | 2017 |
Vulnerability in research ethics: a way forward.
Topics: Adenine; Alzheimer Disease; Anti-HIV Agents; Cambodia; Community-Based Participatory Research; Ethics Committees, Research; Ethics, Research; HIV Infections; Human Experimentation; Humans; Informed Consent; Moral Obligations; Organophosphonates; Primary Prevention; Randomized Controlled Trials as Topic; Research Personnel; Research Subjects; Sex Workers; Tenofovir; Vulnerable Populations | 2013 |
Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases.
Topics: Allosteric Site; Alzheimer Disease; Catalytic Domain; Crystallography, X-Ray; Diphosphonates; Drug Evaluation, Preclinical; Enzyme Inhibitors; Geranyltranstransferase; Humans; Ligands; Neurodegenerative Diseases; Organophosphonates; Phosphorylation; Polymorphism, Single Nucleotide; Pyrimidines; tau Proteins | 2014 |
Mild mitochondrial metabolic deficits by α-ketoglutarate dehydrogenase inhibition cause prominent changes in intracellular autophagic signaling: Potential role in the pathobiology of Alzheimer's disease.
Topics: Alzheimer Disease; Autophagy; Cell Line, Tumor; Cell Survival; Humans; Intracellular Fluid; Ketoglutarate Dehydrogenase Complex; Mitochondria; Organophosphonates; Signal Transduction; Succinates | 2016 |
Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein.
Topics: Alzheimer Disease; Animals; Arachidonic Acids; Drug Evaluation, Preclinical; Frontal Lobe; Hippocampus; Humans; Male; Neurons; Organophosphonates; Phospholipase A2 Inhibitors; Phospholipases A2; Rats; Rats, Wistar; tau Proteins | 2011 |
Inhibition of phospholipase A₂ in rat brain modifies different membrane fluidity parameters in opposite ways.
Topics: Alzheimer Disease; Animals; Arachidonic Acids; Brain; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Male; Membrane Fluidity; Organophosphonates; Phospholipase A2 Inhibitors; Phospholipases A2; Rats; Rats, Wistar | 2011 |
Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer's disease.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Alzheimer Disease; Animals; Binding Sites; Caco-2 Cells; Drug Design; Humans; Ligands; Mice; Molecular Docking Simulation; Organophosphonates; Quantitative Structure-Activity Relationship; Thiazoles | 2013 |